Update on endothelins - Biology and clinical implications

Pediatric Nephrology

Volumn 16, Issue 9, 2001, Pages 752-762

  Hunley, T E ^a   Kon, V ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute renal failure; Congestive heart failure; Development; Endothelin; Endothelin receptor; Hypertension

Indexed keywords

BIG ENDOTHELIN 1; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN 3; ISOPROTEIN; VASOCONSTRICTOR AGENT;

BIOLOGY; BIOSYNTHESIS; CONGESTIVE HEART FAILURE; FETUS MATURITY; HEART DEVELOPMENT; HUMAN; HYPERTENSION; INTESTINE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INTERACTION; RECEPTOR BINDING; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; EMBRYONIC AND FETAL DEVELOPMENT; ENDOTHELINS; HEART DISEASES; HUMANS; HYPERTENSION; KIDNEY FAILURE; LUNG DISEASES; MOLECULAR SEQUENCE DATA; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN;

EID: 0034873702     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670100631     Document Type: Review

References (84)

1. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
2. The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes
3. Endothelin: New discoveries and rapid progress in the clinic
4. Molecular pharmacology and pathophysiological significance of endothelin
5. Secretory pathways in endothelin synthesis
6. Proteolytic processing of big endothelin 3 by Kell blood group protein
7. Cloning of human PEX cDNA
8. Neonatal lethality in mice deficient in XCE, a novel member of the endothelin-converting enzyme and neutral endopeptidase family
9. XCE, a new member of the endothelin-converting enzyme and neutral endopeptidase family, is preferentially expressed in the CNS
10. A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter molecular cloning and characterization
11. Endothelin converting enzyme. Ultrastructural localization and its recycling from the cell surface
12. Cyclic expression of endothelin-converting enzyme-1 mediates the functional regulation of seminiferous tubule contraction
13. Disruption of ECE-1 and ECE-2 reveals a role for endothelin converting enzyme-2 in murine cardiac development
14. Polar secretion of endothelin1 by cultured endothelial cells
15. Cloning and expression of a cDNA encoding an endothelin receptor
16. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
17. Site specific regulation in the kidney of endothelin and its receptor subtypes by cyclosporine
18. Endothelin-1 receptor antagonist: Effects on endothelin- and cyclosporine-treated mesangial cells
19. An endothelin-1 mediated autocrine loop involved in human renal tubule regeneration
20. Endothelin receptor subtype B mediates autoinduction of endothelin-1 in rat mesangial cell
21. Signaling pathways activated by endothelin stimulation of renal cells
22. Endothelin: Pathways of transmembrane signaling
23. Endothelin-1 production by rat inner medullary collecting duct: Effect of nitric oxide, cGMP, and immune cytokines
24. Termination of endothelin signaling: Role of nitric oxide
25. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1
26. Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice
27. Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1
28. Role of endothelin-1/endothelin-A-receptor-mediated signaling pathway in the aortic arch patterning in mice
29. Developmental toxicity and toxicokinetics of two endothelin receptor antagonists in rats and rabbits
30. Pharmacological inactivation of the endothelin type A receptor in the early chick embryo: A model of mispatterning of the branchial arch derivatives
31. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice
32. Interaction of endothelin3 with endothelin B receptor is essential for development of epidermal melanocyte and enteric neurons
33. Transgenic expression of the endothelin-B receptor prevents congenital intestinal aganglionosis in a rat model of Hirschsprung disease
34. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease
35. Novel mutation of the endothelin B receptor gene in patients with Hirschsprung's disease and their characterizations
36. Mutational analysis of the endothelin-B receptor gene in Japanese Hirschsprung's disease
37. A heterozygous frameshift mutation in the endothelin-3 (EDN-3) gene in isolated Hirschsprung's disease
38. Inhibition of in vitro enteric neuronal development by endothelin-3: Mediation by endothelin B receptors
39. Endothelin and neural crest development
40. Endothelin-3 frames shift mutation in congenital central hypoventilation syndrome
41. Forearm vasoconstriction to endothelin-1 is mediated by ETA and ETB receptors in vivo in humans
42. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction
43. Endothelin-induced conversion of embryonic heart muscle cells into impulse-conducting Purkinje fibers
44. Role of endothelin-1 in hypertension
45. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes
46. Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: Evidence for an endothelin-mediated mechanism
47. Endothelin-1 expression in hearts of transgenic hypertensive mice overexpressing angiotensin II
48. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators
49. Elevations of blood pressure by genetic and pharmacological disruption of the ETB receptor in mice
50. Endothelin-A receptor antagonist-mediated vasodilation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade
51. Elevation of blood pressure by genetic and pharmacological disruption of the ETB receptor in mice
52. Hypertension in black patients: An emerging role of the endothelin system in salt-sensitive hypertension
53. Remarkable improvement in long-term mortality and prevention of unfavorable ventricular remodeling by inhibition of the upregulated myocardial endothelin pathway in rats with chronic heart failure
54. Expression of endothelin-1, endothelin converting enzyme, and endothelin receptors in chronic congestive heart failure
55. Endothlein-1: A new target of therapeutic interventions for the treatment of heart failure
56. Heart failure and endothelin receptor antagonists
57. Endothelin receptor antagonism in patients with chronic heart failure
58. Endothelins in health and disease: An overview
59. Early increase in endothelin-1 in tracheal aspirates of preterm infants: Correlation with bronchopulmonary dysplasia
60. Sputum endothelin-1 is increased in cystic fibrosis and chronic obstructive pulmonary disease
61. Endothelin-1 and endothelin-receptors in lung biopsies of patients with pulmonary hypertension due to congenital heart disease
62. Endothelin A receptor blockade decreases pulmonary vascular resistance in premature lambs with hyaline membrane disease
63. Early therapeutic experience with the endothelin antagonist BQ-123 in pulmonary hypertension after congenital heart surgery
64. IL-4 renders mast cells functionally responsive to endothelin-1
65. Respiratory syncytial virus induces the expression of 5-lipoxygenase and endothelin-1 in bronchial epithelial cells
66. Erythromycin and clarithromycin attenuate cytokine-induced endothelin-1 expression in human bronchial epithelial cells
67. Glomerular actions of endothelin in vivo
68. The role of endothelin in acute renal failure
69. Radiocontrast agents induce endothelin release in vivo and in vitro
70. Endothelin in the normal and diseased kidney
71. Reversal of postischemic acute renal failure with a selective endothelin A receptor antagonist in the rat
72. Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension
73. Using transgenic mice to analyze the mechanisms of progression of chronic renal failure
74. Proteinuria overload activates proximal tubule cells to release vasoactive and inflammatory mediators
75. Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II affects fibrosis. Studies in chronic cyclosporine nephrotoxicity in rats
76. Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: Evidence for an endothelin-mediated mechanism
77. A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression
78. Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine A
79. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism
80. Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome)
81. A missense mutation in the endothelin B receptor gene is associated with lethal white foal syndrome: An equine version of Hirschsprung disease
82. A dinucleotide mutation in the ETB receptor gene is associated with lethal white foal syndrome; a horse variant of Hirschsprung disease
83. Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene
84. A loss-of-function mutation in the endothelin-converting enzyme 1 (ECE-1) gene associated with Hirschsprung disease, cardiac defects, and autonomic dysfunction